Back

Prevalence of transthyretin cardiac amyloidosis in a community-based heart failure population

31 August 2019 (12:40 - 13:30)
Organised by:
Congress Presentation Part of: Dilated, infiltrative and inflammatory cardiomyopathies Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Bjorn Pilebro

Umea University Hospital, Umea (Sweden)

6 More presentations in this session

Presentation thumbnail
Prospective FU in various subtypes of cardiomyopathies: insights from the EORP Cardiomyopathy Registry of the ESC
Doctor J. Gimeno Blanes (Murcia, ES)
Abstract Slides
Presentation thumbnail
A descriptive analysis of patients with wild-type ATTR cardiomyopathy from the transthyretin amyloidosis outcomes survey
Doctor P. Garcia-Pavia (Majadahonda, ES)
Abstract Slides
Presentation thumbnail
Natural history, reversibility and arrhythmias associated with truncating titin variants in dilated cardiomyopathy
Doctor C. Vissing (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Combined assessment using clinical and imaging parameters to predict response to pharmacotherapy in patients with dilated cardiomyopathy
Doctor Y. Ikeda (Sagamihara, JP)
Abstract Slides
Presentation thumbnail
The factors associated with death, transplantation and appropriate defibrillators shocks in patients with dilated cardiomyopathy depending on its etiology.
Professor O. Blagova (Moscow, RU)
Abstract Slides

Access the full session

Session thumbnail
Dilated, infiltrative and inflammatory cardiomyopathies

The Event

Event poster

ESC Congress 2019

31 August 2019 12:40 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources